Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Maraviroc 150mg tablets
0503010ADAAAAAA
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 20mg/ml oral solution sugar free
0503010ADAAACAC
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 25mg tablets
0503010ADAAAEAE
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 300mg tablets
0503010ADAAABAB
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maraviroc 75mg tablets
0503010ADAAADAD
|
Maraviroc | Maraviroc | Infections | No data available |
|
Maviret 100mg/40mg tablets
0503032K0BBAAAA
|
Maviret | Glecaprevir/pibrentasvir | Infections | No data available |
|
Mefoxin 1g powder for solution for injection vials
0501021E0BBAAAD
|
Mefoxin | Cefoxitin sodium | Infections | No data available |
|
Mefoxin 2g powder for solution for injection vials
0501021E0BBABAE
|
Mefoxin | Cefoxitin sodium | Infections | No data available |
|
Mepacrine 50mg capsules
0504040M0AAAGAG
|
Mepacrine hydrochloride | Mepacrine hydrochloride | Infections | No data available |
|
Meronem 1g powder for solution for injection vials
0501022A0BBABAB
|
Meronem | Meropenem | Infections | No data available |
|
Meropenem 2g powder for solution for injection vials
0501022A0AAAFAF
|
Meropenem | Meropenem | Infections | No data available |
|
Metrolyl 1g suppositories
0501110C0BFAEAH
|
Metrolyl | Metronidazole | Infections | No data available |
|
Metrolyl 500mg suppositories
0501110C0BFADAG
|
Metrolyl | Metronidazole | Infections | No data available |
|
Metronidazole 100mg/20ml solution for infusion ampoules
0501110C0AAADAD
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 100mg/5ml oral liquid
0501110C0AABLBL
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 200mg suppositories
0501110C0AABJBJ
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 400mg tab and Nystatin 100,000unit pess
0501110C0AAA8A8
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 500mg/100ml solution for infusion bottles
0501110C0AAAKAK
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 500mg/5ml oral suspension
0501110C0AABSBS
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 50mg/5ml oral liquid
0501110C0AABRBR
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metronidazole 50mg/5ml oral suspension
0501110C0AABUBU
|
Metronidazole (Systemic) | Metronidazole | Infections | No data available |
|
Metrozol 500mg/100ml infusion 100ml bags
0501110C0BQAABA
|
Metrozol | Metronidazole | Infections | No data available |
|
Micafungin 100mg powder for solution for infusion vials
0502040B0AAAAAA
|
Micafungin | Micafungin | Infections | No data available |
|
Micafungin 50mg powder for solution for infusion vials
0502040B0AAABAB
|
Micafungin | Micafungin | Infections | No data available |
|
Mictral granules 7g sachets
0501120N0BDAAAC
|
Mictral | Nalidixic acid | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.